These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1869100)

  • 41. Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Sznurkowski J; Emerich J
    Adv Med Sci; 2012 Jun; 57(1):46-50. PubMed ID: 22430042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
    Alberts DS; Liu PY; Hannigan EV; O'Toole R; Williams SD; Young JA; Franklin EW; Clarke-Pearson DL; Malviya VK; DuBeshter B
    N Engl J Med; 1996 Dec; 335(26):1950-5. PubMed ID: 8960474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.
    Creasman WT; Omura GA; Brady MF; Yordan E; DiSaia PJ; Beecham J
    Gynecol Oncol; 1990 Dec; 39(3):239-43. PubMed ID: 2258063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian cancer: an analysis of forty-four patients at the National Radiotherapy Centre, Accra--Ghana.
    Vanderpuye V; Yarney J
    West Afr J Med; 2007; 26(2):93-6. PubMed ID: 17939307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer.
    Beller U; Speyer J; Colombo N; Sorich J; Wernz J; Hochster H; Zeleniuch-Jacquotte A; Porges R; Beckman EM
    J Clin Oncol; 1991 May; 9(5):809-17. PubMed ID: 2016624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin.
    Stratton JA; Kucera PR; Rettenmaier MA; Dobashi K; Micha JP; Braly PS; Berman ML; DiSaia PJ
    Gynecol Oncol; 1986 Nov; 25(3):302-10. PubMed ID: 3781341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma.
    Hakes TB; Chalas E; Hoskins WJ; Jones WB; Markman M; Rubin SC; Chapman D; Almadrones L; Lewis JL
    Gynecol Oncol; 1992 Jun; 45(3):284-9. PubMed ID: 1612505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of advanced ovarian cancer with sequential combination chemotherapy.
    Griffin TW; Hunter RA; Cederbaum AI; Tak WK; Ward AD; Schwartz JH; Halpin TF; Strauss GM; Meyer RN; Liepman MK
    Cancer; 1987 Nov; 60(9):2150-5. PubMed ID: 2830953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of malignant ovarian immature teratoma. Role of adriamycin.
    Vergote IB; Abeler VM; Kjørstad KE; Tropé C
    Cancer; 1990 Sep; 66(5):882-6. PubMed ID: 2201432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
    Hainsworth JD; Burnett LS; Jones HW; Grosh WW; Johnson DH; Greco FA
    J Clin Oncol; 1990 Mar; 8(3):502-8. PubMed ID: 2407811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4'-epi-doxorubicin in the treatment of advanced ovarian cancer.
    Hernádi Z; Juhász B; Póka R; Lampé LG
    Int J Gynaecol Obstet; 1988 Oct; 27(2):199-204. PubMed ID: 2903085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered.
    Gershenson DM; Mitchell MF; Atkinson N; Silva EG; Kavanagh JJ; Morris M; Burke TW; Warner D; Wharton JT
    Gynecol Oncol; 1992 Oct; 47(1):7-13. PubMed ID: 1427404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer.
    Kohn EC; Sarosy GA; Davis P; Christian M; Link CE; Ognibene FP; Sindelar WF; Jacob J; Steinberg SM; Premkumar A; Reed E
    Gynecol Oncol; 1996 Aug; 62(2):181-91. PubMed ID: 8751547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.
    Grem J; O'Dwyer P; Elson P; Simon N; Trump D; Frontiera M; Falkson G; Vogl S
    J Clin Oncol; 1991 Oct; 9(10):1793-800. PubMed ID: 1919629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer.
    Kaye SB; Lewis CR; Paul J; Duncan ID; Gordon HK; Kitchener HC; Cruickshank DJ; Atkinson RJ; Soukop M; Rankin EM
    Lancet; 1992 Aug; 340(8815):329-33. PubMed ID: 1353804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamide.
    Gershenson DM; Wharton JT; Copeland LJ; Stringer CA; Edwards CL; Kavanagh JJ; Freedman RS
    Gynecol Oncol; 1989 Mar; 32(3):336-41. PubMed ID: 2920954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.